FDA Inspection 1269586 — Jiangsu Yuanchuang Pharmaceutical Research and Development Co., Ltd.
The FDA completed an inspection of Jiangsu Yuanchuang Pharmaceutical Research and Development Co., Ltd. on March 26, 2025 in Lianyungang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 26, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)